Gracillin shows potent efficacy against colorectal cancer through inhibiting the STAT3 pathway

Colorectal cancer (CRC) accounts for about 10% of all annually diagnosed cancers and cancer‐related deaths worldwide. STAT3 plays a vital role in the occurrence and development of tumours. Gracillin has shown a significant antitumour activity in tumours, but its mechanism remains unknown. The human...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lehe, Zhu, Tianru, Ye, Hua, Shen, Yili, Li, Zhiping, Chen, Luye, Wang, Canwei, Chen, Xia, Zhao, Haiyang, Xiang, Youqun, Xiao, Zhongxiang, Zhao, Chengguang, Li, Jifa, Hu, Wanle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812262/
https://www.ncbi.nlm.nih.gov/pubmed/33259114
http://dx.doi.org/10.1111/jcmm.16134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812262/
https://www.ncbi.nlm.nih.gov/pubmed/33259114
http://dx.doi.org/10.1111/jcmm.16134

Ejemplares similares